Largest health care companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
UnitedHealth Group leads the 158 health care companies ranked by revenue, at CHF 377.7B, ahead of McKesson (CHF 340.5B) and CVS Health (CHF 339.3B). Figures as of 19 Nov 2026, 20:59 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 158
- First
- UnitedHealth GroupCHF 377.7B
- Median
- CHF 3.4B
- Combined market value
- CHF 7.53T
- Countries
- 14
- Not ranked
- 12no revenue on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Hims & Hers HealthHIMS · Health Care | CHF 2B | CHF 3.2B | CHF 13.52 | 6.01% down | 49% down | ||
| 102 | ExelixisEXEL · Health Care | CHF 2B | CHF 13.6B | CHF 55.53 | 3.65% down | 63% up | ||
| 103 | NateraNTRA · Health Care | CHF 1.9B | CHF 35.5B | CHF 244.95 | 0.26% up | 28% up | ||
| 104 | Concentra Group Holdings ParentCON · Health Care | CHF 1.8B | CHF 4.4B | CHF 34.99 | 1.09% down | 116% up | ||
| 105 | QiagenQGEN · Health Care | CHF 1.8B | CHF 8.6B | CHF 41.88 | 0.14% up | 9% up | ||
| 106 | RadNetRDNT · Health Care | CHF 1.7B | CHF 4.6B | CHF 58.58 | 3.36% down | 9% down | ||
| 107 | TeleflexTFX · Health Care | CHF 1.7B | CHF 5.5B | CHF 138.22 | 1.25% down | 58% up | ||
| 108 | ModernaMRNA · Health Care | CHF 1.6B | CHF 68B | CHF 168.10 | 1.22% up | 780% up | ||
| 109 | MSA SafetyMSA · Health Care | CHF 1.6B | CHF 5.8B | CHF 149.32 | 0.29% down | 16% up | ||
| 110 | PTC TherapeuticsPTCT · Health Care | CHF 1.5B | CHF 4.1B | CHF 49.15 | 3.30% down | 21% down | ||
| 111 | Lantheus HoldingsLNTH · Health Care | CHF 1.3B | CHF 5.6B | CHF 86.17 | 0.10% up | 90% up | ||
| 112 | Merit Medical SystemsMMSI · Health Care | CHF 1.3B | CHF 4.3B | CHF 71.20 | 1.82% down | 1% up | ||
| 113 | AlkermesALKS · Health Care | CHF 1.2B | CHF 6.6B | CHF 38.99 | 1.39% down | 66% up | ||
| 114 | LifeStance Health GroupLFST · Health Care | CHF 1.2B | CHF 4.3B | CHF 11.25 | 3.23% down | 123% up | ||
| 115 | PenumbraPEN · Health Care | CHF 1.2B | CHF 10.6B | CHF 270.00 | 0.21% down | 15% up | ||
| 116 | Halozyme TherapeuticsHALO · Health Care | CHF 1.2B | CHF 8.9B | CHF 78.47 | 2.94% down | 39% up | ||
| 117 | LivaNovaLIVN · Health Care | CHF 1.2B | CHF 4.3B | CHF 77.70 | 2.61% down | 77% up | ||
| 118 | HaemoneticsHAE · Health Care | CHF 1.1B | CHF 4.6B | CHF 101.57 | 2.04% down | 64% up | ||
| 119 | HealthEquityHQY · Health Care | CHF 1.1B | CHF 6.8B | CHF 82.33 | 0.25% up | 3% down | ||
| 120 | Bio-TechneTECH · Health Care | CHF 1B | CHF 9.6B | CHF 61.36 | 0.05% down | 24% up | ||
| 121 | Legend BiotechLEGN · Health Care | CHF 868.3M | CHF 2.6B | CHF 13.56 | 1.11% down | 41% down | ||
| 122 | Guardant HealthGH · Health Care | CHF 828.8M | CHF 16.6B | CHF 122.94 | 0.37% up | 45% up | ||
| 123 | Madrigal PharmaceuticalsMDGL · Health Care | CHF 808.8M | CHF 7.8B | CHF 334.75 | 0.36% down | 27% down | ||
| 124 | Ionis PharmaceuticalsIONS · Health Care | CHF 796.4M | CHF 3.8B | CHF 22.96 | 0.66% down | 63% down | ||
| 125 | Arrowhead PharmaceuticalsARWR · Health Care | CHF 700M | CHF 5.2B | CHF 36.86 | 1.32% up | 13% up | ||
| 126 | Caris Life SciencesCAI · Health Care | CHF 685.3M | CHF 4.5B | CHF 15.63 | 5.00% down | 19% down | ||
| 127 | Ascendis PharmaASND · Health Care | CHF 674.3M | CHF 14.1B | CHF 215.58 | 5.50% down | 29% up | ||
| 128 | Corcept TherapeuticsCORT · Health Care | CHF 642.6M | CHF 6B | CHF 54.80 | 4.22% down | 10% down | ||
| 129 | RepligenRGEN · Health Care | CHF 623M | CHF 9.2B | CHF 143.87 | 1.27% down | 12% up | ||
| 130 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CHF 571.8M | CHF 6.2B | CHF 78.92 | 1.61% down | 129% up | ||
| 131 | 10x GenomicsTXG · Health Care | CHF 542.5M | CHF 6.4B | CHF 48.42 | 0.53% up | 247% up | ||
| 132 | Axsome TherapeuticsAXSM · Health Care | CHF 538.8M | CHF 6B | CHF 114.53 | 1.28% up | 6% down | ||
| 133 | TG TherapeuticsTGTX · Health Care | CHF 520.1M | CHF 8.3B | CHF 54.76 | 1.86% down | 117% up | ||
| 134 | InsmedINSM · Health Care | CHF 511.8M | CHF 26.7B | CHF 121.84 | 20.51% up | 40% down | ||
| 135 | Mirum PharmaceuticalsMIRM · Health Care | CHF 440M | CHF 5.3B | CHF 80.69 | 3.37% up | 34% up | ||
| 136 | GlaukosGKOS · Health Care | CHF 428.2M | CHF 11.9B | CHF 201.20 | 2.29% up | 145% up | ||
| 137 | BridgeBio PharmaBBIO · Health Care | CHF 423.7M | CHF 12.8B | CHF 65.94 | 0.16% up | 21% up | ||
| 138 | Travere TherapeuticsTVTX · Health Care | CHF 414.1M | CHF 3.9B | CHF 40.77 | 3.84% down | 45% up | ||
| 139 | Krystal BiotechKRYS · Health Care | CHF 328.4M | CHF 7.9B | CHF 266.80 | 0.26% up | 54% up | ||
| 140 | Twist BioscienceTWST · Health Care | CHF 317.8M | CHF 6.4B | CHF 94.22 | 4.05% down | 346% up | ||
| 141 | BillionToOneBLLN · Health Care | CHF 257.5M | CHF 3.6B | CHF 76.02 | 1.59% down | 4% down | ||
| 142 | Adaptive BiotechnologiesADPT · Health Care | CHF 233.7M | CHF 3.8B | CHF 23.65 | 1.53% down | 74% up | ||
| 143 | Ligand PharmaceuticalsLGND · Health Care | CHF 226.2M | CHF 4.8B | CHF 242.26 | 3.90% down | 50% up | ||
| 144 | Rhythm PharmaceuticalsRYTM · Health Care | CHF 160.1M | CHF 6.8B | CHF 98.79 | 1.66% down | 18% up | ||
| 145 | HeartflowHTFL · Health Care | CHF 148.6M | CHF 3.3B | CHF 37.59 | 2.94% down | 66% up | ||
| 146 | GRAILGRAL · Health Care | CHF 124.2M | CHF 4B | CHF 88.45 | 2.65% up | 19% up | ||
| 147 | ImmunityBioIBRX · Health Care | CHF 95.6M | CHF 5.9B | CHF 5.54 | 2.09% down | 232% up | ||
| 148 | CytokineticsCYTK · Health Care | CHF 74.3M | CHF 6.1B | CHF 43.43 | 0.28% up | 19% down | ||
| 149 | Protagonist TherapeuticsPTGX · Health Care | CHF 38.8M | CHF 6.8B | CHF 104.62 | 2.51% down | 51% up | ||
| 150 | Kymera TherapeuticsKYMR · Health Care | CHF 33.1M | CHF 8.6B | CHF 100.56 | 1.63% down | 87% up | ||
| 151 | Roivant SciencesROIV · Health Care | CHF 7M | CHF 23.8B | CHF 32.88 | 0.59% up | 91% up | ||
| 152 | CG OncologyCGON · Health Care | CHF 3.4M | CHF 6.2B | CHF 69.11 | 2.36% up | 97% up | ||
| 153 | CRISPR TherapeuticsCRSP · Health Care | CHF 3M | CHF 3.2B | CHF 32.84 | 3.18% down | 18% down | ||
| 154 | Dianthus TherapeuticsDNTH · Health Care | CHF 1.7M | CHF 4B | CHF 71.61 | 1.04% up | 108% up | ||
| 155 | Revolution MedicinesRVMD · Health Care | CHF 0 | CHF 29.1B | CHF 134.55 | 0.24% down | 129% up | ||
| 156 | Spyre TherapeuticsSYRE · Health Care | CHF 0 | CHF 7.8B | CHF 82.42 | 3.75% down | 332% up | ||
| 157 | Praxis Precision MedicinesPRAX · Health Care | CHF 0 | CHF 7.3B | CHF 262.60 | 1.96% up | 86% up | ||
| 158 | Scholar Rock HoldingSRRK · Health Care | CHF 0 | CHF 5.2B | CHF 42.44 | 4.76% up | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8439 CHF). 12 companies have no revenue on file and are not ranked here.
Questions and answers
Which health care companies rank first by revenue?
UnitedHealth Group (CHF 377.7B), McKesson (CHF 340.5B) and CVS Health (CHF 339.3B) are the top three of the 158 health care companies ranked by revenue as of 19 Nov 2026, 20:59 UTC.
How many health care companies are in this ranking?
158 are ranked by revenue. 12 more have no revenue on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 158 health care companies ranked by revenue have a combined market value of CHF 7.53T as of 19 Nov 2026, 20:59 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care companies by revenue”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.